Skip to content
Catholic Online Logo

By Catholic Online (NEWS CONSORTIUM)

9/13/2012 (1 year ago)

Catholic Online (www.catholic.org)

Medical officials point out that medication is not effective as other drugs on market

A medication intended to help those suffering from multiple sclerosis, or MS, entitled Aubagio will soon be on the market. This comes as welcome news to drug maker Sanofi, as it will put them on a multi-billion dollar playing field. Medical officials wish to remind others that Aubagio is not as effective as other drugs intended to treat MS.

Aubagio 'has clear limitations,' doctors write. 'We doubt the drug will seriously affect Gilenya or Tysabri, where prescriptions are largely driven by efficacy.'

Aubagio "has clear limitations," doctors write. "We doubt the drug will seriously affect Gilenya or Tysabri, where prescriptions are largely driven by efficacy."

Article Highlights

By Catholic Online (NEWS CONSORTIUM)

Catholic Online (www.catholic.org)

9/13/2012 (1 year ago)

Published in Health

Keywords: Multiple sclerosis, Aubagio, FDA, drugs, drug industry


LOS ANGELES, CA (Catholic Online) - Meant to be administered once a day, the Food and Drug Administration approved the medicine for relapsing forms of the debilitating disease. Aubagio goes under the scientific name of teriflunomide and is for patients in the initial phases of the disease, the Paris-based Sanofi said.

Sales may be limited because the drug isn't as effective as Novartis AG's Gilenya, the first MS pill approved in Europe, or Tysabri from Elan Corp. and Biogen Idec Inc. Biogen's oral drug BG-12 also may also shortly win U.S. approval by the end of the year.

Aubagio "has clear limitations," doctors write. "We doubt the drug will seriously affect Gilenya or Tysabri, where prescriptions are largely driven by efficacy."

According to estimates compiled by Bloomberg, the treatment may garner annual sales of $330 million in 2016.

Genzyme executives say that the treatment will be an important option for many MS patients.

Aubagio's safety is "very well characterized," and the medicine "is in a different place, targeting a different patient population" from Gilenya. Michael Panzara, Genzyme's therapeutic area head for multiple sclerosis and immune diseases says that Gilenya has "an evolving safety profile, which we continue to learn about every day," he said.

Multiple sclerosis is characterized by an abnormal immune response that attacks the protective covering that surrounds nerve cells in the brain and spinal cord. Nerve cells are prevented from sending signals, sapping patients' energy, blurring their vision and slowly robbing them of mobility, balance and coordination.

Patients using Aubagio had a release rate of about 30 percent lower than the rate for those taking a placebo. The drug will carry a boxed warning about the risk of liver toxicity and birth defects.

Much more common in women than in men, multiple sclerosis is believed to affect more than 2.1 million people worldwide. Many patients have trouble staying on current therapies as the drugs are difficult to use or cause side effects.

Aubagio will cost $45,000 a year in the U.S., 28 percent less than Gilenya. The lower price is due to the fact that Aubagio is less effective than the Novartis product and carries the risk of liver side effects.

.

---


Pope Francis: end world hunger through 'Prayer and Action'


2014 - Distributed by THE NEWS CONSORTIUM

Pope Francis Prayer Intentions for April 2014
Ecology and Justice:
That governments may foster the protection of creation and the just distribution of natural resources.
Hope for the Sick: That the Risen Lord may fill with hope the hearts of those who are being tested by pain and sickness.



Comments


More Health

DEADLY BACTERIA: Dreaded MRSA virus now infecting U.S. homes Watch

Image of Bedding, clothes and other everyday surfaces used by someone affected by MRSA are suggested to be cleaned by bleach and hot water.

By Catholic Online (NEWS CONSORTIUM)

The anti-biotic resistant "superbug" known as methicillin-resistant Staphylococcus aureus, or MRSA for short, is a deadly drug-resistant virus that plagues mostly hospitals. A new report has found that virus can now incubate in private residences, meaning that ... continue reading


WHICH IS WORSE? 'I'd rather have HIV than diabetes,' one controversial doctor says Watch

Image of Dr. Max Pemberton say that it is now very rare for someone to die of HIV in the U.K. and that, in fact, people with the virus have a very similar life expectancy to people who are HIV-negative.

By Catholic Online (NEWS CONSORTIUM)

At one time, HIV and AIDS was considered a horrifying death sentence. There was no way to control it, and those who suffered from it would suffer, long painful deaths as their faculties fell away. Diabetes, on the other hand, was a given for those who ... continue reading


Death lurks about the cutting board: Kitchens could be sources of drug-resistant bacteria, experts warn Watch

Image of Ironically, the cutting board -- and NOT the knife, represents the greatest threat to health and safety, experts say.

By Catholic Online (NEWS CONSORTIUM)

There's a killer lurking undetected in many ordinary kitchens, experts warn. Cutting boards used to prepare raw poultry may be an important source of drug-resistant bacteria in both hospital kitchens and private homes, a new study warns. LOS ANGELES, CA ... continue reading


Uh-oh! One in every 20 adults seeking medical care walks away misdiagnosed Watch

Image of In little more than five percent of cases, the original diagnosis was wrong and could have been accurately detected by the information available in the first setting.

By Catholic Online (NEWS CONSORTIUM)

If you're diligent and go to your doctor regularly - you still may not be getting a clean bill of health. According to a new study, one in 20 Americans who see their doctor may walk away having their condition misdiagnosed. Twelve million Americans a year could ... continue reading


Analysis: Millions wasted on shoddy flu drug, Tamiflu Watch

Image of The analysis, from the Cochrane Collaboration claims Tamiflu did not prevent the spread of flu or reduce dangerous complications.

By Catholic Online (NEWS CONSORTIUM)

It's an especially harsh analysis for a drug that many people keep in their bathroom mirror for a sudden outbreak of the sniffles. A new analysis says that many millions may have been wasted on Tamiflu, a common drug used to treat flu symptoms. According to the ... continue reading


Deadly H5N1 bird flu virus could easily mutate to spread from human to human Watch

Image of When the healthy ferret developed flu symptoms, such as ruffled fur, loss of appetite and lack of energy - researchers knew the virus had spread through the air.

By Catholic Online (NEWS CONSORTIUM)

The avian flu, or H5N1 virus was so deadly scientists once halted research as governments feared it might be used by terrorists to stage a biological attack. The dreaded H5N1 avian influenza has since killed 60 percent of the 650 humans known to be infected ... continue reading


Scottish scientists successfully regenerate organ in mouse - could humans be next? Watch

Image of After the regeneration, the treated mice also started to make more T-cells, which is a type of white blood cell key to fighting infections.

By Catholic Online (NEWS CONSORTIUM)

A breakthrough which may pave the way for the technique to be used in humans has been uncovered by Scottish scientists. Researchers have been able to fully restore an organ in a living animal for the first time.  LOS ANGELES, CA (Catholic Online) - The team ... continue reading


New drug used to treat breast cancer heralded as 'quite groundbreaking' Watch

Image of While Pfizer remains in the lead to bring this new class of drugs to market, Novartis has begun late-stage testing of its own CDK 4/6 inhibitor.

By Catholic Online (NEWS CONSORTIUM)

An important treatment option in the fight against breast cancer may be waiting in the wings. Researchers say a new type of drug could help prevent advanced breast cancer from worsening. The potential is great for breast cancer patients, and makes for a ... continue reading


Delicious Earl Grey tea found to have hidden health benefit Watch

Image of Bergamot is a Mediterranean citrus fruit which gives Earl Grey its distinct taste and smell. It has enjoyed popularity among the upper and middle classes.

By Catholic Online (NEWS CONSORTIUM)

Many drink it for its taste and the enjoyment it brings, without thought of it being "good for them." Scientists now say that Earl Grey tea can lower cholesterol and reduce the chances of heart disease. LOS ANGELES, CA (Catholic Online) - A popular beverage ... continue reading


Deaf since birth, woman hears - for the first time Watch

Image of Deaf since birth, 40-year-old Joanne Milne received cochlear implants - and is now learning to hear the world for the very first time. Electronic implants were switched on, and Milne burst into tears when the sound of a nurse reciting the days of the week gave her the first sensation of sound.

By Catholic Online (NEWS CONSORTIUM)

Deaf since birth, 40-year-old Joanne Milne received cochlear implants - and is now learning to hear the world for the very first time. Electronic implants were switched on, and Milne burst into tears when the sound of a nurse reciting the days of the week gave ... continue reading


All Health News

Newsletters

Newsletter Sign Up icon

Stay up to date with the latest news, information, and special offers

Daily Readings

Reading 1, Acts 3:1-10
1 Once, when Peter and John were going up to the ... Read More

Psalm, Psalms 105:1-2, 3-4, 6-7, 8-9
1 Alleluia! Give thanks to Yahweh, call on his name, ... Read More

Gospel, Luke 24:13-35
13 Now that very same day, two of them were on their ... Read More

Saint of the Day

Saint of the Day for April 23rd, 2014 Image

St. George
April 23: Pictures of St. George usually show him killing a dragon to ... Read More

Inform, Inspire & Ignite Logo

Find Catholic Online on Facebook and get updates right in your live feed.

Become a fan of Catholic Online on Facebook


Follow Catholic Online on Twitter and get News and Product updates.

Follow us on Twitter